BDH Industries
370.00
+3.40(+0.93%)
Market Cap₹213.16 Cr
PE Ratio20.25
IndustryHealthcare
Company Performance:
1D+0.93%
1M-1.08%
6M-14.02%
1Y+37.85%
5Y+270.74%
View Company Insightsright
More news about BDH Industries
11Aug 25
BDH Industries Reports 15.2% Revenue Growth and 16.5% Profit Increase in Q1 FY2026
BDH Industries Limited reported strong Q1 FY2026 results with total income rising 15.2% to ₹1,916.98 lakhs. Net profit increased 16.5% to ₹182.66 lakhs, and EPS improved to ₹3.17 from ₹2.72. The company maintained a solid financial position with unchanged equity share capital at ₹575.73 lakhs and other equity at ₹6,168.35 lakhs. Results were published in compliance with SEBI regulations.
 no imag found
08Aug 25
BDH Industries Approves Q1 FY 2025-26 Financial Results and Holds 35th AGM
BDH Industries' Board of Directors approved Q1 FY 2025-26 unaudited financial results on August 8, 2025. The company held its 35th Annual General Meeting via video conferencing, with 40 shareholders participating. Key AGM proceedings included adopting financial statements, declaring dividends, and re-appointing directors. Ms. Jayashree Nair was re-appointed as Managing Director, and Mr. S. C. Kachhara was re-designated and re-appointed as Managing Director. The company provided e-voting facilities for shareholders and committed to publishing financial results in newspapers as per SEBI regulations.
 no imag found
BDH Industries
370.00
+3.40
(+0.93%)
1 Year Returns:+37.85%
Industry Peers
Sun Pharmaceutical
1,877.90
(+0.79%)
Divis Laboratories
6,815.00
(-1.54%)
Torrent Pharmaceuticals
4,420.60
(+0.38%)
Cipla
1,437.20
(+0.03%)
Dr Reddys Laboratories
1,321.20
(+1.35%)
Lupin
2,279.00
(+0.92%)
Mankind Pharma
2,508.30
(+1.87%)
Zydus Life Science
1,013.60
(+2.21%)
Aurobindo Pharma
1,515.70
(+0.32%)
Laurus Labs
1,325.20
(+0.74%)